Literature DB >> 16987496

Attention control in middle childhood: relations to psychopathological symptoms and threat perception distortions.

Peter Muris1, Cor Meesters, Linda Rompelberg.   

Abstract

The present study examined the construct of attention control, which is an important aspect of effortful control, in a sample of non-clinical children aged between 9 and 13 years. Results demonstrated that attention control was associated with a broad range of psychopathological complaints, including symptoms of anxiety, aggression, depression, and ADHD. As predicted, lower levels of attention control were accompanied by higher levels of these symptoms. Further, attention control was also negatively related to threat perception distortions, which indicates that children who display low levels of this regulative temperament factor are more prone to such cognitive biases. Third, when controlling for neuroticism, attention control remained significantly (negatively) associated with symptoms of anxiety, depression (child report only), and ADHD. The correlations between attention control and threat perception distortions largely disappeared when the influence of neuroticism was partialled out. Only the link between attention control and anxious interpretations of ambiguous vignettes survived this correction. Finally, no evidence was found for the hypothesised mediating role of cognitive distortions on the relation between temperament factors and psychopathological symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16987496     DOI: 10.1016/j.brat.2006.07.010

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  25 in total

1.  Executive Attention at Eight Years: Concurrent and Longitudinal Predictors and Individual Differences.

Authors:  Amanda W Joyce; Denise R Friedman; Christy D Wolfe; Martha Ann Bell
Journal:  Infant Child Dev       Date:  2017-10-19

2.  Underlying personality characteristics of behavioral inhibition in children.

Authors:  Peter Muris; Roeland Dietvorst
Journal:  Child Psychiatry Hum Dev       Date:  2006

3.  Community Violence Exposure and Generalized Anxiety Symptoms: Does Executive Functioning Serve a Moderating Role Among Low Income, Urban Youth?

Authors:  Darcy E Burgers; Deborah A G Drabick
Journal:  J Abnorm Child Psychol       Date:  2016-11

4.  Predicting internalizing problems in Chinese children: the unique and interactive effects of parenting and child temperament.

Authors:  Luma Muhtadie; Qing Zhou; Nancy Eisenberg; Yun Wang
Journal:  Dev Psychopathol       Date:  2013-08

Review 5.  Integrating etiological models of social anxiety and depression in youth: evidence for a cumulative interpersonal risk model.

Authors:  Catherine C Epkins; David R Heckler
Journal:  Clin Child Fam Psychol Rev       Date:  2011-12

6.  Interactive Contributions of Cumulative Peer Stress and Executive Function Deficits to Depression in Early Adolescence.

Authors:  Anna M Agoston; Karen D Rudolph
Journal:  J Early Adolesc       Date:  2015-07-06

7.  Attentional Control Scale for Children: Factor Structure and Concurrent Validity Among Children and Adolescents Referred for Anxiety Disorders.

Authors:  Raquel Melendez; Michele Bechor; Yasmin Rey; Jeremy W Pettit; Wendy K Silverman
Journal:  J Clin Psychol       Date:  2016-07-26

8.  Childhood fears, neurobehavioral functioning and behavior problems in school-age children.

Authors:  Jonathan Kushnir; Avi Sadeh
Journal:  Child Psychiatry Hum Dev       Date:  2009-07-28

9.  Temperament and risk for depressive symptoms in adolescence: mediation by rumination and moderation by effortful control.

Authors:  Katrien Verstraeten; Michael W Vasey; Filip Raes; Patricia Bijttebier
Journal:  J Abnorm Child Psychol       Date:  2009-04

10.  Symptoms of anxiety, depression, and aggression in non-clinical children: relationships with self-report and performance-based measures of attention and effortful control.

Authors:  Peter Muris; Els van der Pennen; Rianne Sigmond; Birgit Mayer
Journal:  Child Psychiatry Hum Dev       Date:  2008-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.